US Bancorp’s Zymeworks ZYME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.23K | Sell |
315
-37
| -11% | -$940 | ﹤0.01% | 3513 |
|
|
2026
Q1 | $8.81K | Buy |
352
+65
| +23% | +$1.54K | ﹤0.01% | 3397 |
|
|
2025
Q4 | $7.56K | Buy |
287
+39
| +16% | +$851 | ﹤0.01% | 3420 |
|
|
2025
Q3 | $4.24K | Hold |
248
| – | – | ﹤0.01% | 3584 |
|
|
2025
Q2 | $3.11K | Sell |
248
-175
| -41% | -$2.08K | ﹤0.01% | 3767 |
|
|
2025
Q1 | $5.04K | Sell |
423
-65
| -13% | -$886 | ﹤0.01% | 3657 |
|
|
2024
Q4 | $7.14K | Sell |
488
-416
| -46% | -$5.82K | ﹤0.01% | 3543 |
|
|
2024
Q3 | $11.3K | Sell |
904
-558
| -38% | -$6.08K | ﹤0.01% | 3322 |
|
|
2024
Q2 | $12.4K | Sell |
1,462
-334
| -19% | -$2.97K | ﹤0.01% | 3234 |
|
|
2024
Q1 | $18.9K | Buy |
1,796
+261
| +17% | +$2.9K | ﹤0.01% | 3124 |
|
|
2023
Q4 | $15.9K | Buy |
1,535
+137
| +10% | +$1.09K | ﹤0.01% | 3142 |
|
|
2023
Q3 | $8.86K | Buy |
1,398
+228
| +19% | +$1.68K | ﹤0.01% | 3219 |
|
|
2023
Q2 | $10.1K | Buy |
+1,170
| New | +$10.5K | ﹤0.01% | 3258 |
|
|
2022
Q3 | – | Sell |
-46
| Closed | – | – | 4243 |
|
|
2022
Q2 | $0 | Sell |
46
-318
| -87% | -$1.92K | ﹤0.01% | 4263 |
|
|
2022
Q1 | $2K | Buy |
364
+17
| +5% | +$152 | ﹤0.01% | 3872 |
|
|
2021
Q4 | $5K | Sell |
347
-326
| -48% | -$6.8K | ﹤0.01% | 3676 |
|
|
2021
Q3 | $20K | Hold |
673
| – | – | ﹤0.01% | 3143 |
|
|
2021
Q2 | $23K | Sell |
673
-5,792
| -90% | -$184K | ﹤0.01% | 3068 |
|
|
2021
Q1 | $204K | Sell |
6,465
-318
| -5% | -$12.9K | ﹤0.01% | 1915 |
|
|
2020
Q4 | $321K | Buy |
6,783
+689
| +11% | +$32K | ﹤0.01% | 1660 |
|
|
2020
Q3 | $284K | Buy |
6,094
+4,763
| +358% | +$164K | ﹤0.01% | 1613 |
|
|
2020
Q2 | $48K | Sell |
1,331
-131
| -9% | -$4.83K | ﹤0.01% | 2445 |
|
|
2020
Q1 | $52K | Sell |
1,462
-1,543
| -51% | -$63.1K | ﹤0.01% | 2347 |
|
|
2019
Q4 | $137K | Hold |
3,005
| – | – | ﹤0.01% | 2013 |
|
|
2019
Q3 | $75K | Buy |
3,005
+1,505
| +100% | +$37.7K | ﹤0.01% | 2286 |
|
|
2019
Q2 | $33K | Hold |
1,500
| – | – | ﹤0.01% | 2715 |
|
|
2019
Q1 | $24K | Hold |
1,500
| – | – | ﹤0.01% | 2794 |
|
|
2018
Q4 | $22K | Hold |
1,500
| – | – | ﹤0.01% | 2784 |
|
|
2018
Q3 | $24K | Buy |
1,500
+500
| +50% | +$7.16K | ﹤0.01% | 2867 |
|
|
2018
Q2 | $15K | Buy |
+1,000
| New | +$15.5K | ﹤0.01% | 3031 |
|
Other funds holding ZYME
EC
RCMNY
PA
BI
NI
US Bancorp's ZYME Position: Q2 2026 in Review
US Bancorp reduced its Zymeworks (ZYME) stake by 11% in Q2 2026, selling an estimated $940 and leaving 315 shares worth $8.23K. The position accounts for ﹤0.01% of the portfolio, ranked #3513.
US Bancorp first reported a position in ZYME in Q2 2018 and has held it in 30 quarters since. The position peaked at $321K in Q4 2020. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.
- US Bancorp held 315 shares of Zymeworks worth $8.23K as of Q2 2026.
- US Bancorp sold 37 Zymeworks shares in Q2 2026, an estimated $940.
- Zymeworks made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3513 holding.
- US Bancorp first reported a position in Zymeworks in Q2 2018 and has held it in 30 quarters since.
- US Bancorp's Zymeworks position peaked at $321K in Q4 2020.
- 203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.